CVS vs VCYT: fair value comparison
CVS Health Corporation and Veracyte, Inc. · Updated 2026-08-31
CVS currently screens as overvalued while VCYT screens as fairly valued. Within Healthcare, VCYT currently sits closer to the top of our discount ranking. VCYT carries the stronger quality grade.
| CVS | VCYT | |
|---|---|---|
| Verdict | Overvalued | Fairly valued |
| Last price | $93.06 | $44.85 |
| 12-month range | $72.49–$105.37 | $30.11–$59.85 |
| Sector rank | #88 of 113 Healthcare | #85 of 113 Healthcare |
| Quality grade | F | A |
| Leverage | Moderate | Low |
| Margin trend | Stable | Expanding |
| Revenue growth | Modest | Strong |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | — | Mixed |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The upper-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: CVS fair value analysis · VCYT fair value analysis